Primary |
Rheumatoid Arthritis |
30.0% |
Atrial Fibrillation |
20.0% |
Hypertension |
20.0% |
Blood Folate Decreased |
10.0% |
Hyperuricaemia |
10.0% |
Prophylaxis Against Gastrointestinal Ulcer |
10.0% |
|
|
Secondary |
Rheumatoid Arthritis |
63.5% |
Product Used For Unknown Indication |
5.0% |
Osteoporosis Prophylaxis |
4.5% |
Osteoporosis |
3.5% |
Hypertension |
3.0% |
Burkitt's Lymphoma |
2.5% |
Hodgkin's Disease Mixed Cellularity Stage Unspecified |
2.0% |
Juvenile Arthritis |
2.0% |
Psoriasis |
2.0% |
Psoriatic Arthropathy |
2.0% |
Juvenile Idiopathic Arthritis |
1.5% |
Mental Disorder |
1.5% |
Antibiotic Prophylaxis |
1.0% |
Drug Toxicity Prophylaxis |
1.0% |
Drug Use For Unknown Indication |
1.0% |
Pain |
1.0% |
Prophylaxis |
1.0% |
Thrombosis Prophylaxis |
1.0% |
Acne |
0.5% |
Asthma |
0.5% |
|
Pulmonary Fibrosis |
12.1% |
Renal Cancer |
12.1% |
Colon Cancer |
6.1% |
Pancytopenia |
6.1% |
Postoperative Wound Infection |
6.1% |
Saliva Altered |
6.1% |
Sepsis |
6.1% |
Skin Erosion |
6.1% |
Subileus |
6.1% |
Abdominal Hernia |
3.0% |
Abdominal Pain |
3.0% |
Diarrhoea |
3.0% |
Erysipelas |
3.0% |
Flatulence |
3.0% |
Inappropriate Schedule Of Drug Administration |
3.0% |
Migraine |
3.0% |
Neoplasm |
3.0% |
Pancreatitis |
3.0% |
Pleural Effusion |
3.0% |
Pulmonary Function Test Decreased |
3.0% |
|
Concomitant |
Rheumatoid Arthritis |
33.5% |
Product Used For Unknown Indication |
20.2% |
Drug Use For Unknown Indication |
18.3% |
Hypertension |
4.1% |
Polyarthritis |
3.3% |
Osteoporosis |
2.8% |
Crohn's Disease |
2.7% |
Psoriatic Arthropathy |
2.7% |
Diabetes Mellitus |
1.7% |
Juvenile Idiopathic Arthritis |
1.3% |
Osteoporosis Prophylaxis |
1.3% |
Arthralgia |
0.9% |
Asthma |
0.9% |
Back Pain |
0.9% |
Gastroenteritis |
0.9% |
Hypertonia |
0.9% |
Prophylaxis |
0.9% |
Spondylitis |
0.9% |
Vitamin Supplementation |
0.9% |
Ankylosing Spondylitis |
0.8% |
|
Urticaria |
10.3% |
Weight Decreased |
8.8% |
Osteoarthritis |
7.4% |
Psoriasis |
7.4% |
Respiratory Failure |
7.4% |
Cervix Carcinoma Stage 0 |
5.9% |
Nasopharyngitis |
5.9% |
Tuberculosis |
5.9% |
Pulmonary Tuberculosis |
4.4% |
Tendon Rupture |
4.4% |
Transaminases Increased |
4.4% |
Traumatic Brain Injury |
4.4% |
B-cell Lymphoma |
2.9% |
Bursitis |
2.9% |
Endometrial Adenocarcinoma |
2.9% |
Myelodysplastic Syndrome |
2.9% |
Oedematous Pancreatitis |
2.9% |
Ophthalmic Herpes Zoster |
2.9% |
Pancreatitis Chronic |
2.9% |
Pleural Effusion |
2.9% |
|
Interacting |
Rheumatoid Arthritis |
42.9% |
Hypertension |
28.6% |
Osteoporosis |
14.3% |
Prophylaxis Against Gastrointestinal Ulcer |
14.3% |
|
Implant Site Effusion |
40.0% |
Tracheobronchitis |
40.0% |
Helicobacter Infection |
20.0% |
|